BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

778 related articles for article (PubMed ID: 19469800)

  • 1. Innovative 19-minute rapid cytokeratin immunostaining of nonmelanoma skin cancer in Mohs micrographic surgery.
    Cherpelis BS; Turner L; Ladd S; Glass LF; Fenske NA
    Dermatol Surg; 2009 Jul; 35(7):1050-6. PubMed ID: 19469800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of MART-1 frozen sections to permanent sections using a rapid 19-minute protocol.
    Cherpelis BS; Moore R; Ladd S; Chen R; Glass LF
    Dermatol Surg; 2009 Feb; 35(2):207-13. PubMed ID: 19215257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of paraffin sections in association with Mohs micrographic surgery for nonmelanoma skin cancers.
    Ebede TL; Lee EH; Dusza SW; Busam KJ; Nehal KS
    Dermatol Surg; 2012 Oct; 38(10):1631-8. PubMed ID: 22958072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mohs micrographic surgery for the management of nonmelanoma skin cancers.
    Cumberland L; Dana A; Liegeois N
    Facial Plast Surg Clin North Am; 2009 Aug; 17(3):325-35. PubMed ID: 19698914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of antidesmoglein stains in Mohs micrographic surgery. A potential aid for the differentiation of basal cell carcinoma from horizontal sections of the hair follicle and folliculocentric basaloid proliferation.
    Krunic AL; Garrod DR; Viehman GE; Madani S; Buchanan MD; Clark RE
    Dermatol Surg; 1997 Jun; 23(6):463-8. PubMed ID: 9217798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical margins in the treatment of nonmelanoma skin cancer and mohs micrographic surgery.
    Lane JE; Kent DE
    Curr Surg; 2005; 62(5):518-26. PubMed ID: 16125611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of touch imprint cytology and Mohs frozen-section histology in the evaluation of Mohs micrographic surgical margins.
    Florell SR; Layfield LJ; Gerwels JW
    J Am Acad Dermatol; 2001 Apr; 44(4):660-4. PubMed ID: 11260543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dense inflammation does not mask residual primary basal cell carcinoma during Mohs micrographic surgery.
    Katz KH; Helm KF; Billingsley EM; Maloney ME
    J Am Acad Dermatol; 2001 Aug; 45(2):231-8. PubMed ID: 11464184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical techniques in Mohs micrographic surgery: their potential use in the detection of neoplastic cells masked by inflammation.
    Jimenez FJ; Grichnik JM; Buchanan MD; Clark RE
    J Am Acad Dermatol; 1995 Jan; 32(1):89-94. PubMed ID: 7529778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 20-minute rapid MART-1 immunostain for malignant melanoma frozen sections.
    Kimyai-Asadi A; Ayala GB; Goldberg LH; Vujevich J; Jih MH
    Dermatol Surg; 2008 Apr; 34(4):498-500. PubMed ID: 18248466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid HMB-45 staining in Mohs micrographic surgery for melanoma in situ and invasive melanoma.
    Menaker GM; Chiang JK; Tabila B; Moy RL
    J Am Acad Dermatol; 2001 May; 44(5):833-6. PubMed ID: 11312433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mohs micrographic surgery of primary cutaneous mucinous carcinoma using immunohistochemistry for margin control.
    Marra DE; Schanbacher CF; Torres A
    Dermatol Surg; 2004 May; 30(5):799-802. PubMed ID: 15099329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of a novel 1-hour protocol for rapid frozen section immunocytochemistry, in a case of squamous cell carcinoma treated with Mohs micrographic surgery.
    Sinha K; Ali F; Orchard G; Rickaby W; Shams M; Mallipeddi R; Patalay R
    Clin Exp Dermatol; 2018 Jun; 43(4):454-457. PubMed ID: 29396855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cytokeratin markers for rapid frozen section immunocytochemistry from head and facial Mohs cases of basal cell carcinoma: a comparison and evaluation to determine the marker of choice.
    Orchard GE; Wojcik K; Shams F; Georgaki E; Quaye CJ; Fernando P; Torres J; Ismail F; Shams M
    Br J Biomed Sci; 2015; 72(2):61-6. PubMed ID: 26126321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of Mohs micrographic surgery: review of the literature.
    Tierney EP; Hanke CW
    J Drugs Dermatol; 2009 Oct; 8(10):914-22. PubMed ID: 19852120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant cytokeratin staining in Mohs micrographic surgery for basal cell carcinoma.
    Smeets NW; Stavast-Kooy AJ; Krekels GA; Daemen MJ; Neumann HA
    Dermatol Surg; 2003 Apr; 29(4):375-7. PubMed ID: 12656816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mohs micrographic surgery: a synopsis.
    Stone JL
    Hawaii Med J; 1993 May; 52(5):134-9. PubMed ID: 8320092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mohs frozen tissue sections in comparison to similar paraffin-embedded tissue sections in identifying perineural tumor invasion in cutaneous squamous cell carcinoma.
    Green JS; Tournas JA; Allen EJ; Youker SR; Fosko SW
    J Am Acad Dermatol; 2012 Jul; 67(1):113-21. PubMed ID: 22533992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of synchronous and metachronous second nonmelanoma skin cancer when referred for Mohs micrographic surgery.
    Schinstine M; Goldman GD
    J Am Acad Dermatol; 2001 Mar; 44(3):497-9. PubMed ID: 11209121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
    Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
    Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.